The Columbia Renal Biopsy Course 2025 (Videos + Slides)
$60.00
Video Course · Nephrology · 2025
Three days of intensive renal biopsy interpretation from 24 expert nephropathologists — including Vivette D’Agati, Glen Markowitz, Agnes Fogo, and Ronald Falk — covering glomerular disease, crescentic GN, dysproteinemia, and transplant pathology.
-
3days
-
22lectures
-
24faculty
-
2025year
- Live clinical case discussions throughout
- Genetic testing integration with biopsy findings
- Complement diseases, APOL1, and lupus nephritis
- 3 months of streaming access included
Renal biopsy interpretation — pathology, genetics, and treatment from Columbia experts
The Columbia Renal Biopsy Course 2025 brings nephrologists and renal pathologists face-to-face with the diagnostic and therapeutic challenges of medical renal disease. Over three days starting July 16, 2025, twenty-four faculty members — including Vivette D’Agati, Glen Markowitz, Agnes Fogo, and Ronald Falk — deliver lectures on glomerular, tubulointerstitial, vascular, and transplant pathology, paired with live clinical case discussions that test your biopsy interpretation skills in real time.
-
3days
-
22lectures
-
24faculty
-
2025year
Inside this resource
Glomerular disease pathology and treatment approaches
Day one covers the histophysiology of the glomerulus, MCD and FSGS pathology and therapy, membranous nephropathy including new antigens, MPGN and C3 glomerulopathy, and diabetic kidney disease pathology. Laurence Beck addresses immune surveillance in membranous nephropathy while Andrew Bomback walks through C3 glomerulopathy diagnosis and management.
Crescentic GN, ANCA vasculitis, and IgA nephropathy
Day two opens with J. Charles Jennette on crescentic glomerulonephritis and ANCA/anti-GBM disease, followed by Ronald Falk on treatment. M. Barry Stokes covers IgA nephropathy and IgA vasculitis pathology while Pietro Canetta addresses modern treatment approaches. Infection-related GN and the 41st Conrad L. Pirani Lecture by D’Agati round out the morning.
Dysproteinemia, TMA, and transplant pathology
Samih Nasr reviews renal amyloidosis, fibrillary GN, and monoclonal immunoglobulin crystalline nephropathies. Thrombotic microangiopathy pathology and treatment are paired with viral-mediated glomerular disease. Day three closes with transplant pathology — Robert Colvin on rejection and Ibrahim Batal on drug toxicity, infections, and recurrent disease.
Genetics integration and lupus nephritis
Agnes Fogo addresses hereditary nephropathies while Dominick Santoriello and Hila Milo Rasouly demonstrate how to integrate genetic testing with renal biopsy findings. Simone Sanna-Cherchi delivers the state-of-the-art lecture on APOL1 updates, and lupus nephritis receives dedicated sessions on pathology and modern therapies.
Who this serves
- Nephrologists — interpreting renal biopsies and correlating pathology with clinical management
- Renal pathologists — staying current with classification updates and novel diagnostic criteria
- Trainees — building foundational skills in renal pathology and genetic testing integration
Faculty & syllabus
Faculty 24 speakers
- Vivette D. D’Agati, MD — Histophysiology of the Glomerulus, 41st Conrad L. Pirani Lecture, Lupus Nephritis Pathology
- Glen S. Markowitz, MD — MN Pathology, Welcome and Introduction, Pathology of Nephrotoxicity
- Agnes B. Fogo, MD — MCD and FSGS, Hereditary Nephropathies
- Gerald B. Appel, MD — Current Therapy of MCD and FSGS, Modern Therapies for Lupus Nephritis
- Sanjeev Sethi, MD, PhD — Membranous Nephropathy: New Antigens and New Insights
- Laurence H. Beck, Jr., MD, PhD — Treatment and Immune Surveillance in MN
- Miroslav Sekulic, MD — MPGN and C3 Glomerulopathy: Pathology
- Andrew S. Bomback, MD, MPH — C3 Glomerulopathy: Diagnosis and Management
- Charles E. Alpers, MD — Pathology of Diabetic Kidney Disease
- Michelle A. Hladunewich, MD, FRCP(C), MSc — Glomerular Disease in Pregnancy
- J. Charles Jennette, MD — Crescentic Glomerulonephritis and ANCA and Anti-GBM Disease
- Ronald J. Falk, MD — Treatment of Crescentic Glomerulonephritis
- M. Barry Stokes, MD — Pathology of IgA Nephropathy and IgA Vasculitis, TMA and Viral Glomerular Disease Pathology
- Pietro Canetta, MD — Treatment of IgA Nephropathy and IgA Vasculitis
- Leal C. Herlitz, MD — Infection Related Glomerulonephritis
- Dominick Santoriello, MD — Dysproteinemic Renal Disease, Integrating the Renal Biopsy with Genetic Testing
- Samih H. Nasr, MD — Renal Amyloidosis, Fibrillary GN, Monoclonal Immunoglobulin Crystalline Nephropathies
- Jai Radhakrishnan, MD, MS — Treatment of Thrombotic Microangiopathy
- Meghan E. Sise, MD, MS — Viral-mediated Glomerular Disease, Onconephrology Clinical Aspects of Drug Toxicity
- Simone Sanna-Cherchi, MD — Updates on APOL1
- Robert B. Colvin, MD — Renal Transplant Pathology Part 1: Rejection
- Ibrahim Batal, MD — Renal Transplant Pathology Part 2: Drug Toxicity, Infections, and Recurrent and De Novo Glomerular Disease
- Satoru Kudose, MD — Acute Interstitial Nephritis
- Hila Milo Rasouly, PhD — Integrating the Renal Biopsy with Genetic Testing
Before you buy
How long is access after purchase?
You receive 3 months of streaming access to all lectures from the conference, including both live and virtual participation formats.
Is this suitable for nephrology trainees?
Yes — the course is designed for nephrologists, renal pathologists, and trainees in both specialties.
The chart
| Format | Video Course (22 lectures + slides) |
|---|---|
| Year | 2025 |
| Publisher | Columbia University |
| Department | Nephrology |
| Delivery | Instant download after checkout · lifetime re-access |
Verified original fileInstant downloadEncrypted checkout
6 reviews for The Columbia Renal Biopsy Course 2025 (Videos + Slides)
Add a review
Related products
Nephrology
Nephrology
Nephrology
Jennifer H. –
As a renal pathologist, this course keeps me current with classification changes. The complement disease sessions were particularly relevant.
Mark P. –
Three-day course packed with actionable pathology knowledge. The lupus nephritis sessions alone were worth the investment.
Sandra L. –
Wished for more on drug toxicity pathology — the onconephrology section felt brief. The glomerular disease content was outstanding though.
Robert T. –
Excellent pathology content throughout. The biopsy case discussions were the most valuable part — real-time interpretation practice.
Claire M. –
The genetic testing integration session with Santoriello and Rasouly was exactly what I needed for my daily biopsy practice.
Andrew G. –
D’Agati and Markowitz are the gold standard in renal pathology. Having both teach in one course is an extraordinary opportunity.